1 / 7

Artificial Organ And Bionics Market Outlook 2020

ncreasing number of accidents and growing rate of man-made hazards are anticipated to drive the market for artificial organs and medical bionics market over the forecast period.

hexaresearchindustry
Download Presentation

Artificial Organ And Bionics Market Outlook 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Your Catalyst To a Lucrative Business Artificial Organ and Bionics Market Analysis, Size, Share, Growth, Industry Insights and Forecast to 2020 | Hexa Research “Increasing number of accidents and growing rate of man-made hazards are anticipated to drive the market for artificial organs and medical bionics market over the forecast period.” Continuous technological innovations coupled with high investments in healthcare are two key factors that fuel the global Artificial Organ and Bionics Market. Artificial organs refer to devices that are developed to replace natural organs in the human body. The need for organ transplant arises when a certain natural organ has either stopped working or doesn’t function properly. Artificial organs and artificial body parts are made from substances known as biomaterials. Man made hazards and high frequency of accidents may propel the global artificial organ and bionics market during the forecast period (2014 to 2020). Artificial liver, artificial limbs, artificial pancreas, artificial heart, and artificial kidneys are examples of artificial organs that function exactly like natural organs when implanted in the human body. The application of electronics & mechanics in the field of medicine has led to newer innovations in developing artificial organs. Browse Details of Report @ https://www.hexaresearch.com/research-report/artificial-organs-and-bionics- industry Follow Us:

  2. Your Catalyst To a Lucrative Business The worldwide artificial organ and bionics market is categorized on the basis of products, technologies, and regions. Based on products, the segments are artificial pancreas, artificial liver, artificial lungs, artificial heart, and artificial kidney. Medical bionics products are further subdivided into cardiac bionics, brain bionics, vision bionics, heart bionics, limb bionics, and exoskeleton bionics. Due to high prevalence of heart disorders worldwide, the segment for heart bionics holds the largest share in the overall market. The artificial lungs & kidney segments held considerable industry shares in 2013. These segments may grow substantially during the forecast period because of problems, such as alcohol abuse and consumption of drugs & cigarettes. On the basis of technologies, the industry is bifurcated into mechanical bionics and electronic bionics. Rapid technological advancements have led to the development of medical bionics that meets the challenges of organ failure. Mechanical bionics is mostly employed in the development of orthopedic body parts. As per regions, the global artificial organ and bionics market is categorized into Europe, Asia Pacific, North America, and Rest of the World. North America led the industry in 2013. Factors that fuel this region are high investments in research & development and technological advancements. Growing geriatric population, rising cases of organ failure, and high incidence of accidents may contribute to regional growth over the forecast period. However, the Asia Pacific market is poised to grow rapidly over the next couple of years. This industry is driven by steady government support, medical tourism, and surging disposable incomes. Government support has led to improvements in healthcare infrastructures. Companies in the worldwide artificial organ and bionics market are Second Sight Medical Product Inc.; Medtronic Co. Ltd.; World Heart Corporation; Thoratec Corporation; and Lifenet Health. Besides being monopolistic, the global market is a highly competitive one too. Researchers have begun examining using 3D printing in the development of artificial organs. Organovo, a U.S. based biotech startup, focuses on 3D printing of human tissues. These are then sculpted in layers to form organs. Nano Dimension, an Israeli 3D printing company in collaboration with Accellta has successfully mixed human stem cells in printing inks. Accellta is an Israel based stem cell technology company. The striking feature of the inkjet methods of Nano Dimension is the speed at which it prints the human tissues. While most 3D printing techniques take hours to perform this task, Nano Dimension’s technology does it in a matter of seconds. Browse Related Category Reports @ https://www.hexaresearch.com/research-category/healthcare-it- industry Follow Us:

  3. Your Catalyst To a Lucrative Business Table of Content of Artificial Organ And Bionics Market Chapter 1. Executive Summary 1.1. Artificial organ- Industry Summary & Critical Success Factors (CSFs) Chapter 2. Artificial organ Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Artificial organ Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Artificial organ- Company Market Share Analysis, 2013 2.7. Artificial organ market PESTEL Analysis, 2013 Chapter 3. Artificial organ Product Outlook 3.1. Artificial organs 3.1.1. Global artificial organ demand, 2012 - 2020 (USD Million) 3.1.1.1. Global total artificial heart demand, 2012 - 2020 (USD Million) 3.1.1.2. Global artificial pancreas demand, 2012 - 2020 (USD Million) 3.1.1.3. Global artificial liver demand, 2012 - 2020 (USD Million) 3.1.1.4. Global artificial lungs heart demand, 2012 - 2020 (USD Million) 3.1.1.5. Global artificial kidney heart demand, 2012 - 2020 (USD Million) 3.2. Bionic 3.2.1. Global Bionic demand, 2012 - 2020 (USD Million) 3.2.1.1. Global Cochlear implants demand, 2012 - 2020 (USD Million) 3.2.1.2. Global Cardiac Bionic demand, 2012 - 2020 (USD Million) 3.2.1.3. Global Ventricular assist device demand, 2012 - 2020 (USD Million) 3.2.1.4. Global Heart valves demand, 2012 - 2020 (USD Million) 3.2.1.5. Global Mechanical valves demand, 2012 - 2020 (USD Million) 3.2.1.6. Global Biological tissue valves demand, 2012 - 2020 (USD Million) 3.2.1.7. Global Transcatheter heart valves demand, 2012 - 2020 (USD Million) 3.2.1.8. Global Brain bionics demand, 2012 - 2020 (USD Million) 3.2.1.9. Global Spinal cord stimulators demand, 2012 - 2020 (USD Million) 3.2.1.10. Global Deep brain stimulators demand, 2012 - 2020 (USD Million) 3.2.1.11. Global Vagus nerve stimulators demand, 2012 - 2020 (USD Million) 3.2.1.12. Global Exoskeletons demand, 2012 - 2020 (USD Million) Follow Us:

  4. Your Catalyst To a Lucrative Business 3.2.1.13. Global Bionic limbs demand, 2012 - 2020 (USD Million) 3.2.1.14. Global Bionic hands demand, 2012 - 2020 (USD Million) 3.2.1.15. Global Bionic legs demand, 2012 - 2020 (USD Million) 3.2.1.16. Global Vision bionics demand, 2012 - 2020 (USD Million) Chapter 4. Artificial Organ Technology Outlook 4.1. Mechanical bionics 4.1.1. Global mechanical bionic demand, 2012 - 2020 (USD Million) 4.2. Electronic bionics 4.2.1. Global electronic demand, 2012 - 2020 (USD Million) Chapter 5. Artificial organ Regional Outlook 5.1. North America 5.1.1. North America artificial organmarket revenue by product, 2012 - 2020 (USD Million) 5.1.2. North America artificial organmarket revenue by technology, 2012 - 2020 (USD Million) 5.2. Europe 5.2.1. Europe artificial organmarket revenue by product, 2012 - 2020 (USD Million) 5.2.2. Europe artificial organmarket revenue by technology, 2012 - 2020 (USD Million) 5.3. Asia Pacific 5.3.1. Asia Pacific artificial organmarket revenue by product, 2012 - 2020 (USD Million) 5.3.2. Asia Pacific artificial organmarket revenue by product technology, 2012 - 2020 (USD Million) 5.4. RoW 5.4.1. RoW artificial organmarket revenue by product, 2012 - 2020 (USD Million) 5.4.2. RoW artificial organmarket revenue by product technology, 2012 - 2020 (USD Million) Chapter 6 Competitive Landscape 6.1 Abiomed Inc. 6.1.1 Company Overview 6.1.2 Financial Performance 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives 6.2 Asahi Kasei Kuraray Medical Co. Ltd. 6.2.1 Company Overview 6.2.2 Financial Performance 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives 6.3 Thoratec Corporation 6.3.1 Company Overview 6.3.2 Financial Performance Follow Us:

  5. Your Catalyst To a Lucrative Business 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives 6.4 WorldHeart Corp. 6.4.1 Company Overview 6.4.2 Financial Performance 6.4.3 Product Benchmarking 6.4.4 Strategic Initiatives 6.5 Gambro AB 6.5.1 Company Overview 6.5.2 Financial Performance 6.5.3 Product Benchmarking 6.5.4 Strategic Initiatives 6.6 Biomet Inc. 6.6.1 Company Overview 6.6.2 Financial Performance 6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives 6.7 Cochlear Ltd 6.7.1 Company Overview 6.7.2 Financial Performance 6.7.3 Product Benchmarking 6.7.4 Strategic Initiatives 6.8 Berlin Heart Gmbh 6.8.1 Company Overview 6.8.2 Financial Performance 6.8.3 Product Benchmarking 6.8.4 Strategic Initiatives 6.9 Ekso Bionics 6.9.1 Company Overview 6.9.2 Financial Performance 6.9.3 Product Benchmarking 6.9.4 Strategic Initiatives 6.10 Medtronic Inc. 6.10.1 Company Overview 6.10.2 Financial Performance 6.10.3 Product Benchmarking Follow Us:

  6. Your Catalyst To a Lucrative Business 6.10.4 Strategic Initiatives 6.11 Lifenet Health 6.11.1 Company Overview 6.11.2 Financial Performance 6.11.3 Product Benchmarking 6.11.4 Strategic Initiatives 6.12 Heartware International Inc. 6.12.1 Company Overview 6.12.2 Financial Performance 6.12.3 Product Benchmarking 6.12.4 Strategic Initiatives 6.13 Jarvik Heart Inc. 6.13.1 Company Overview 6.13.2 Financial Performance 6.13.3 Product Benchmarking 6.13.4 Strategic Initiatives 6.14 Walk Inc.Ossur 6.14.1 Company Overview 6.14.2 Financial Performance 6.14.3 Product Benchmarking 6.14.4 Strategic Initiatives 6.15 Boston Scientific Corporation 6.15.1 Company Overview 6.15.2 Financial Performance 6.15.3 Product Benchmarking 6.15.4 Strategic Initiatives 6.16 Sorin S.P.A. 6.16.1 Company Overview 6.16.2 Financial Performance 6.16.3 Product Benchmarking 6.16.4 Strategic Initiatives Chapter 7 Methodology and Scope 7.1 Research Methodology 7.2 Research Scope & Assumptions 7.3 List of Data Sources Follow Us:

  7. Your Catalyst To a Lucrative Business About Us: Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives. Contact Us: Ryan Shaw Hexa Research Felton Office Plaza 6265 Highway 9 Felton, California 95018 United States Phone: +1-800-489-3075 Email: sales@hexaresearch.com Website - http://www.hexaresearch.com/ Follow Us:

More Related